Glycine does not raise blood sugar. The simplest amino acid in the human body consistently shows blood-sugar-lowering effects in both human experiments and observational studies, though the way it accomplishes this involves a surprisingly complex set of hormonal and metabolic pathways. People with type 2 diabetes and obesity tend to have low circulating glycine, and supplementation studies have generally pointed toward improved glucose control rather than worsened blood sugar. Here is how the evidence breaks down.
What Happens to Blood Sugar After You Take Glycine
When healthy people swallow glycine on its own, their blood sugar does not spike. A study tracking the metabolic response to ingested glycine found that plasma glycine and glucagon levels rose afterward, and insulin rose slightly as well, but the amino acid did not produce a glucose surge.1PubMed. The metabolic response to ingested glycine That matters because some people worry that any food or supplement capable of stimulating insulin must be pushing blood sugar around in unpredictable ways. In glycine’s case, the insulin nudge appears to be a feature, not a problem.
The more interesting result shows up when glycine is taken alongside carbohydrates. When researchers gave glycine and leucine together with a glucose load, the glucose area response dropped by about two-thirds compared to glucose alone, while the insulin response rose by roughly a quarter.2PubMed Central. Interaction of ingested leucine with glycine on insulin and glucose concentrations The glucose-lowering effect was more dramatic than the modest bump in insulin would explain on its own, which suggests glycine is doing more than just squeezing extra insulin out of the pancreas. The researchers noted that the combined effect was not simply the sum of what each amino acid does individually, pointing to some kind of interaction between the two that amplifies glucose clearance.
How Glycine Triggers Insulin Release
Glycine acts directly on the insulin-producing beta cells of the pancreas. These cells have glycine receptors on their surface, and when glycine binds to them, it opens chloride channels that shift the cell’s electrical charge. In beta cells, this shift actually promotes depolarization, calcium entry, and ultimately insulin secretion.3PubMed. A Glycine-Insulin Autocrine Feedback Loop Enhances Insulin Secretion From Human β-Cells and Is Impaired in Type 2 Diabetes Research on human beta cells has confirmed that blocking these glycine receptors with a chemical called strychnine reduces glucose-stimulated insulin output, which tells us the receptors play an active role in how beta cells sense and respond to glucose.4PubMed Central. Molecular correlates of glycine receptor activity in human β cells
The insulin-boosting story does not stop at the pancreas. Glycine also stimulates the release of GLP-1, a gut hormone that enhances insulin secretion after meals and slows gastric emptying. Cell-line experiments showed that glycine activates glycine receptors on GLP-1-producing cells in the gut, triggering depolarization, calcium influx, and hormone release through a mechanism that strychnine blocks.5PubMed Central. The neurotransmitters glycine and GABA stimulate glucagon-like peptide-1 release from the GLUTag cell line GLP-1 is the same hormone targeted by drugs like semaglutide, so the fact that a simple amino acid taps into this pathway, even modestly, is worth noting.
The Glucagon Complication
Here is where things get more nuanced. Glycine does not just stimulate insulin. It also stimulates glucagon, the hormone that tells the liver to release stored glucose. That sounds like it should raise blood sugar, and in isolation it might. When researchers exposed normal human islets to glycine, glucagon secretion increased in a dose-dependent fashion, with the threshold sitting around 0.3 to 0.5 millimolar and a maximum response at about 1.2 millimolar.6Journal of Biological Chemistry. Metabolic Regulation of Islet Glucagon and Insulin Secretion by Gamma-Hydroxybutyrate and Glycine Importantly, glucose itself suppressed glycine’s glucagon-stimulating effect in these experiments, meaning that in a normal postmeal environment, the glucagon signal gets tamped down.
The mechanism behind this glucagon stimulation is still debated. Standard physiology would predict that activating chloride channels on alpha cells (the cells that make glucagon) should quiet them down. But the intracellular chloride concentration in human alpha cells may be high enough that opening chloride channels actually depolarizes these cells, pushing them toward secretion rather than away from it.7Journal of Endocrinology. α-cell electrophysiology and the regulation of glucagon secretion The net effect, though, still favors glucose lowering in real-world experiments. Glycine pushes both insulin and glucagon upward, but the balance tilts toward better glucose disposal rather than worse.
Can Your Body Turn Glycine Into Sugar
Glycine is classified as a gluconeogenic amino acid, meaning the liver can convert it into glucose. This is the theoretical basis for the concern that glycine might raise blood sugar. Classic perfusion studies in fasted rat livers showed that amino acid mixtures, including glycine, do feed into glucose production, with the rate depending on amino acid concentration.8Journal of Biological Chemistry. Gluconeogenesis from Amino Acids in Perfused Rat Liver
But there is a wide gap between what a fasted rat liver does with an amino acid infusion and what happens in a living person who takes a glycine supplement. In practice, the hormonal responses glycine triggers, particularly the insulin and GLP-1 release discussed above, appear to outweigh its modest contribution as a gluconeogenic substrate. The human trials consistently show a net reduction in blood sugar, not an increase. Gluconeogenesis from glycine is real biochemistry, but it does not dominate the overall metabolic picture in supplementation doses.
Low Glycine as a Marker of Metabolic Trouble
One of the more consistent findings in metabolomics research is that people with obesity, insulin resistance, and type 2 diabetes tend to have lower-than-normal levels of glycine circulating in their blood. This association has appeared across multiple study designs and populations. A review of the evidence found that low plasma glycine predicts the future development of type 2 diabetes in prospective studies, and that higher glycine levels are associated with reduced risk.9PubMed. Insulin resistance and glycine metabolism in humans When people lose weight, exercise, or undergo bariatric surgery, their glycine levels tend to rise as insulin sensitivity improves.10Endocrinology. Impaired “Glycine”-mia in Type 2 Diabetes and Potential Mechanisms Contributing to Glucose Homeostasis
This inverse relationship between glycine and insulin resistance also tracks with body weight. In people with pre-diabetes, the association between low glycine and poor insulin sensitivity becomes stronger as body weight increases.11PubMed. Low serum glycine strengthens the association between branched-chain amino acids and impaired insulin sensitivity assessed before and after weight loss in a population with pre-diabetes This contrasts sharply with branched-chain amino acids like valine and leucine, which move in the opposite direction: they tend to be elevated in insulin resistance and positively linked to adiposity, whereas glycine tracks negatively with those same markers.12Diabetes. Glycine and Branched-Chain Amino Acids (BCAA) Metabolic Signature in Youth with Obesity and Type 2 Diabetes
Whether the low glycine is a cause or a consequence of metabolic dysfunction remains an open question. It could be that insulin resistance burns through glycine faster, or that the metabolic pathways consuming glycine are upregulated in obesity, or that glycine depletion actively contributes to worsening insulin sensitivity. The answer is probably some combination. But the pattern is robust enough that some researchers view glycine levels as a biomarker for metabolic health.
What Supplementation Studies Show
A handful of clinical trials have tested glycine supplementation directly in people with type 2 diabetes or metabolic risk factors. In one trial, patients with type 2 diabetes who received glycine for three months had significantly lower HbA1c levels compared to the placebo group, along with reduced inflammatory markers.13PubMed. Glycine treatment decreases proinflammatory cytokines and increases interferon-gamma in patients with type 2 diabetes HbA1c reflects average blood sugar over roughly two to three months, so a measurable drop suggests that glycine’s glucose-lowering effects are not just a fleeting response to each dose but a sustained improvement.
Animal data adds another angle. In a study using diabetic rats, glycine supplementation reduced blood glucose, HbA1c, and fructosamine levels, and also lowered levels of advanced glycation end products, the harmful compounds that form when sugars stick to proteins.14Journal of Experimental & Clinical Medicine. Effect of Glycine on Protein Oxidation and Advanced Glycation End Products Formation This suggests glycine may protect against some downstream damage of high blood sugar, not just the elevated glucose itself.
Glycine has also been studied in combination with N-acetylcysteine, a pairing sometimes called GlyNAC. A pilot trial in older adults found that 24 weeks of GlyNAC supplementation improved insulin resistance along with oxidative stress, inflammation, and mitochondrial function.15PubMed Central. Glycine and N-acetylcysteine (GlyNAC) supplementation in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance, endothelial dysfunction, genotoxicity, muscle strength, and cognition: Results of a pilot clinical trial The combination works in part because glycine and cysteine are both building blocks for glutathione, the body’s main internal antioxidant. However, a separate randomized trial testing GlyNAC at multiple doses in healthy older adults found no significant change in total glutathione levels compared to placebo for the full group, though people who started with the lowest glutathione and highest oxidative stress markers did show a response.16Frontiers in Aging. A Randomized Controlled Clinical Trial in Healthy Older Adults to Determine Efficacy of Glycine and N-Acetylcysteine Supplementation on Glutathione Redox Status and Oxidative Damage The takeaway: GlyNAC’s benefits may be most apparent in people whose antioxidant defenses are already depleted, not in everyone universally.
Glycine’s Signal to the Brain and Liver
Beyond its direct effects on pancreatic cells and gut hormones, glycine acts through a central nervous system pathway that regulates how much glucose the liver pumps out. The dorsal vagal complex in the brainstem contains NMDA receptors, and glycine helps activate these receptors. When researchers delivered glycine centrally in animal models, hepatic glucose production dropped. This effect depended on an intact vagal nerve connection to the liver; cutting that nerve eliminated glycine’s ability to suppress liver glucose output.17Endocrinology. Impaired “Glycine”-mia in Type 2 Diabetes and Potential Mechanisms Contributing to Glucose Homeostasis – Section: Glycine in the Brain: Evidence for NMDA Receptor Predominance in Glucose Homeostasis Blocking the NMDA receptor pharmacologically also wiped out the glucose-lowering effect, confirming that this receptor is the necessary relay point.
This is a distinct mechanism from the insulin and GLP-1 pathways. It means glycine has at least three separate channels through which it can bring blood sugar down: direct stimulation of insulin release, GLP-1-mediated enhancement of that insulin response, and brain-mediated suppression of liver glucose production. The redundancy helps explain why the net effect in human studies is consistently glucose-lowering, even though glycine simultaneously pokes glucagon upward.
Glycine and Gestational Diabetes Risk
The relationship between glycine and blood sugar extends to pregnancy. A 2025 case-control study examining plasma amino acid profiles found that higher glycine levels were negatively associated with the risk of gestational diabetes. Specifically, glycine and serine showed protective associations, while branched-chain amino acids like valine and isoleucine were associated with increased risk. Glycine was also negatively associated with blood glucose levels in the modeling analysis.18PubMed. Plasma amino acid profiles and gestational diabetes mellitus risk: A case-control study This mirrors the broader metabolomics pattern seen in non-pregnant populations and raises the question of whether glycine status during pregnancy could eventually become a useful clinical marker, though observational associations are not enough to justify supplementation recommendations on their own.
The Gut Microbiome Connection
Emerging research suggests the gut microbiome plays a role in how amino acids influence blood sugar. A study investigating microbiota-encoded metabolic pathways found that microbial genes involved in branched-chain amino acid and tryptophan metabolism can indirectly affect host glucose homeostasis through peripheral serotonin signaling.19Cell Host & Microbe. Gut microbiota-encoded metabolic pathways shape host amino acid landscape and glucose homeostasis While that particular study focused more on branched-chain amino acids than on glycine specifically, it highlights the principle that your body’s amino acid balance, including glycine, is shaped partly by your gut bacteria. The clinical relevance of this for glycine supplementation is still early-stage, but it adds another layer to why individual responses to amino acid interventions can vary.
Safety and Practical Considerations
Glycine supplements are generally well tolerated. In a study of individuals with severe obesity taking daily glycine, no adverse effects were reported, no participants dropped out due to the supplement, and compliance was high at about 93 percent. Participants maintained their usual diets and did not start new medications during the study period.20PubMed Central. Metabolic impact of dietary glycine supplementation in individuals with severe obesity
That said, there is an upper boundary to keep in mind. A review of glycine supplementation literature noted that very high doses, above roughly 500 milligrams per kilogram of body weight, could potentially induce toxic effects related to glutamate buildup.21PubMed Central. An Update of the Promise of Glycine Supplementation for Enhancing Physical Performance and Recovery For a 70-kilogram person, that threshold sits at 35 grams, which is far above the doses used in most clinical trials (typically 3 to 15 grams per day). The typical dietary intake of glycine from food is a few grams daily, coming primarily from collagen-rich animal proteins like skin, connective tissue, and bone broth, along with legumes and certain seeds.
If you are taking diabetes medications, be aware that glycine’s insulin-stimulating and glucose-lowering properties could theoretically add to the blood-sugar-lowering effects of your drugs. This has not been extensively studied, so flagging it with a doctor before starting supplementation makes sense, particularly if you use insulin or sulfonylureas where hypoglycemia risk already exists. For people without diabetes who are curious about glycine as a general metabolic health supplement, the safety profile looks reassuring at commonly used doses, though large-scale long-term trials are still lacking.
Why Glycine Gets Confused With Blood Sugar Raising
The confusion likely stems from a few sources. First, glycine is a gluconeogenic amino acid, so anyone who has taken a biochemistry class might reasonably assume it can become glucose. Second, glycine stimulates glucagon, and glucagon’s whole job is raising blood sugar. Third, some people generalize from the observation that protein-rich meals can raise blood sugar in certain contexts, particularly in people with type 1 diabetes or advanced type 2 diabetes where insulin responses are impaired. In those specific situations, the amino acids in protein can contribute to glucose production that insulin cannot adequately handle.
But glycine taken in isolation or alongside a meal in a person with at least some residual insulin function operates differently from the theoretical worst case. The insulin and GLP-1 responses it triggers, combined with the brain-mediated suppression of liver glucose output, appear to consistently outrun the gluconeogenic and glucagon contributions. The observational data reinforces this: if glycine routinely raised blood sugar, you would expect people with high glycine levels to have worse metabolic profiles, and the opposite is true across dozens of studies and populations.